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abstract: Induced pluripotent stem cells (iPSCs) may be obtained by direct reprogramming of different somatic cells to a pluripotent
state by forced expression of a handful of transcription factors. It was generally assumed that iPSCs are functionally equivalent to their
embryonic stem cell (ESC) counterparts. Recently, a number of research groups have demonstrated that this is not the case, showing
that iPSCs retain ‘epigenetic memory’ of the donor tissue from which they were derived and display skewed differentiation potential.
This raises the question whether such cells are ﬁt for experimental, diagnostic or therapeutic purpose. A brief survey of the literature illus-
trates that differences at both epigenetic and transcriptome level are observed between various pluripotent stem cell populations. Interest-
ingly, iPSC populations with perceived ‘anomalies’ can be coaxed to a more ESC-like cellular state either by continuous passaging—which
attenuates these epigenetic differences—or treatment with small molecules that target the machinery responsible for remodelling the
genome. This suggests that the establishment of an epigenetic status approximating an ESC counterpart is largely a passive process. The
mechanisms responsible remain to be established. Meanwhile, other areas of reprogramming are rapidly evolving such as, trans-differen-
tiation of one somatic cell type to another by the forced expression of key transcription factors. When it comes to assessing their practical
usefulness, the same question will also apply.
Key words: stem cells / epigenetics
The current state of play . . .
It is generally agreed that pluripotent stem cells (PSCs) have huge
experimental, diagnostic and therapeutic potential. However, it is
unclear if inherent differences in the properties of PSCs obtained
from different sources or by different means impact their applicability.
The ability to revert a somatic cell to a pluripotent status has been
achieved in a number of ways, including cell fusion and somatic-cell
nuclear transfer (SCNT) (Gurdon, 1962; Tada et al., 1997; Wilmut
et al., 1997; Tada et al., 2001; Hochedlinger and Jaenisch, 2002).
Recently, it was demonstrated that a somatic cell could be re-assigned
to an embryonic-like state via the forced expression of a handful of key
genes, notably Oct4, Sox2, Klf4 and c-Myc, to an induced pluripotent
stem cell (iPSC) (Takahashi and Yamanka, 2006). This technology is
now in use in many laboratories worldwide and the lines produced
are generally assumed to be functionally equivalent to embryonic
stem cells (ESCs) derived from fertilized embryos (fESCs) or ESCs
generated via SCNT (NT-ESCs). This is assessed by their appearance,
expression of pluripotency markers, ability to form teratomas and, in
the case of murine ESCs, the ability to generate chimaeras or mice
derived completely from iPSCs through tetraploid complementation.
Recently, a number of publications have questioned this, suggesting
that iPSCs, fESCs and NT-ESCs are not equivalent and that iPSCs
retain ‘epigenetic memory’ of the tissue from which they were
derived (Marchetto et al., 2009; Ji et al., 2010; Kim et al., 2010).
Epigenetic differences and
differentiation potential of iPSCs
and ESCs
Kim et al. (2010) examined the impact of reprogramming murine
somatic cell types (ﬁbroblasts and blood) via ‘somatic cell nuclear
transfer’ (SCNT) or forced expression of transcription factors on epi-
genetic parameters and ability to differentiate towards haematopoietic
or osteogenic lineages compared with ESCs derived from a fertilized
oocyte (fESCs). Strikingly, early passage iPSCs generated via forced
expression of transcription factors exhibited vestiges of the methyl-
ation signature of the donor tissue from which they were derived,
while the NT-ESCs exhibited an epigenetic proﬁle very similar to
fESCs. This was taken further by investigating the differentiation poten-
tial of iPSCs derived from either blood or ﬁbroblasts. Again, a
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‘memory’ was observed as the differentiation potential favoured the
donor tissue from which the iPSCs were originally derived. In a
related study, Polo et al. (2010) derived murine iPSCs from a
number of different tissues, ﬁbroblasts, granulocytes, lymphocytes
(haematopoietic) and muscle (myogenic) cells. In agreement with
Kim et al. (2010), early-passage iPSCs appeared to retain an epigenetic
memory of the donor cell of origin and again this was reﬂected in
differential gene expression and altered differentiation capacity. It is
important to emphasize that these two studies were conducted in
murine systems and their relevance to human iPSCs (hiPSCs) is uncer-
tain. However, Marchetto et al. (2009) showed that hiPSCs derived
from neural stem cells (NSC) were generally very similar to hESCs
but the transcriptional proﬁles generated appeared to reveal a gene
expression signature of the donor NSCs. It should be noted that
this study was only undertaken in a single NSC line and requires
further validation. However, these studies indicate that iPSCs poten-
tially retain vestigial epigenetic characteristics consistent with the
tissue from which they are derived (Marchetto et al., 2009; Kim
et al., 2010; Polo et al., 2010).
The above studies complement a related study by Ji et al. (2010),
who investigated whether speciﬁc DNA methylation marks could
play a role in the regulation of developmental progression to a particu-
lar cell lineage. This was assessed by subjecting eight distinct popu-
lations of puriﬁed cells of the haematopoietic system to
comprehensive high-throughput array-based relative methylation
analysis (CHARM). This method determines the CpG methylation
status of both promoters and nearby CpG shores at a genome-wide
level. The outcome of this study demonstrated that lineage fate
during differentiation in terms of commitment to myeloid or lymphoid
development is potentially choreographed by modulation of the levels
of DNA methylation.
It is clear from the above studies that there are differences at the
molecular level between iPSCs and ESCs. However, if we look at
mouse and human ESCs and iPSCs at a gross level, they share many
features, including indeﬁnite self-renewal and pluripotency in terms
of the expression of pluripotency gene networks, the ability to differ-
entiate two different tissue lineages via directed procedures, embryoid
body formation or teratoma and, in the murine situation, the ability to
form a live animal (Carpenter et al., 2003; Rao 2004; Okita et al.,
2007; Smith et al., 2009). But if one scrutinizes these model systems
more closely, they are more divergent and certainly not equivalent.
For example, mouse ESCs require leukaemia inhibitory factor (LIF)
and bone morphogenic protein 4 (BMP4), while hESCs require
activin and ﬁbroblast growth factor 2 (FGF2) signalling (Brons et al.,
2007). This demonstrates that these two cell types are indeed not
equivalent at the molecular level but are still pluripotent. Interestingly,
recent studies have demonstrated that mouse epiblast stem cells
(EpiSC), derived from mouse embryos at post-implantation stage,
are functionally closer to hESCs as they require activin and FGF2 sig-
nalling (Vallier et al., 2007, 2009).
There is other evidence that subtle differences exist between ESCs
and iPSCs. A study by Malchenko et al. (2010) utilizing global compara-
tive analysis of microRNAs (miRs) identiﬁed a number of miRs that
were highly expressed in iPSCs, suggesting that these miRs were
associated with cancers. This study was limited to interrogating two
iPSCs lines and four hESC lines. Two other studies by Chin et al.
(2009) and Wilson et al. (2009) noted that a subset of miRs were
consistently present in hiPSCs compared with hESCs, indicating that
iPSCs may have a unique miR proﬁle.
Aberrant epigenetic proﬁles can
be changed . . .
In an elegant study by Stadtfeld et al. (2010), iPSCs versus ESCs were
compared; note that in this study the pluripotent cells generated were
genetically identical. The data demonstrated that overall the two cell
types at the mRNA and miR level were almost identical, with the
exception of a few transcripts. These differences were mapped to
an imprinted gene cluster in the mouse genome on chromosome
12qF1.
Interestingly, two classes of iPSCs were observed. Those with aber-
rant silencing of the DLk1-Dio3 locus (Gtl2off) did not contribute well
to chimaeras or form animals from tetraploid complementation exper-
iments (all-iPSC mice). On the other hand, iPSCs with proﬁcient
expression from this locus (Gtl2on)—similar to that observed in
their ESC counterpart—generated high-quality chimaeras and, more
importantly, generated all-iPSC mice on tetraploid complementation.
These observations may be a consequence of incomplete reprogram-
ming, as suggested by a rescue experiment in which iPSC-Gtl2off lines
were treated with the histone deacetylase inhibitor, valproic acid
(VPA). Treatment coincided with reactivation of this locus and conse-
quent generation of all-iPSC mice on tetraploid complementation. In
addition, Gtl2 was highly expressed in ﬁbroblasts from which the
iPSCs were generated, whereas iPSCs derived from haematopoietic
cell lineages which expressed low levels of Gtl2 consistently generated
iPSCs with a Gtl2off status. The authors speculate that this may well
be a consequence of epigenetic memory.
Transcriptome analysis, the
algorithm makes the difference!
The global gene expression proﬁles of iPSCs and ESCs derived from
murine and human origins were compared by Chin et al. (2009).
On face value, iPSCs appeared to be similar to ESCs but as observed
by Stadtfeld et al. (2010), gene expression patterns that were speciﬁc
to iPSCs emerged. This was irrespective of their origin or method of
generation. Interestingly, two follow-up studies based on genome-
wide transcriptional analysis of similar data sets described by Chin
et al. (2009) came to different conclusions. First, Guenther et al.
(2010) compared both global chromatin structure and gene
expression proﬁles of a panel of hiPSCs and hESCs. Interestingly,
they observed very little variation with respect to histone H3K4me3
and histone H3K27me3 modiﬁcation in both hiPSCs and hESCs. In
addition, this was reﬂected in gene expression proﬁles that again
exhibited very few differences. Importantly, the observed differences
did not discriminate iPSCs from ESCs as was observed in the study
by Chin et al. (2009). However, Newman and Cooper (2010)
arrived at a very different conclusion. They re-analysed micro-array
data sets from seven different laboratories that interrogated some
17 hESC lines, 67 hiPSCs lines and 18 ﬁbroblast lines. Their analysis
uncovered a striking correlation between the expression proﬁles of
the hiPSCs or hESCs and the laboratory of origin (Fig. 1). This suggests
that much of the available data may be artefacts of laboratory origin
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and reinforces the importance of following best practice in experimen-
tal design and data analysis (Chin et al., 2010). Rigid standard operating
procedures are required to reveal meaningful differences in cellular
properties, as discussed by Loh and Lim (2010). Thus, it appears
that culture conditions and the way the cell lines are handled may gen-
erate a particular laboratory signature on top of which the mode of
reprogramming can still affect the end product (Chin et al., 2010).
These differences are not
restricted to iPSCs . . .
This phenomenon of subtle differences is not restricted to iPSCs
versus ESCs. Abeyta et al. (2004) investigated a number of hESC
lines and discovered that individual lines expressed unique gene signa-
tures. A number of more recent studies demonstrate that ESCs exhibit
variation in terms of their growth proﬁles and differentiation potential.
Some lines exhibit a propensity to differentiate towards speciﬁc
lineages, which is often accompanied with elevated lineage-speciﬁc
gene expression (Osafune et al., 2008) and overall differential gene
expression (Allegrucci and Young, 2007; Sharova et al., 2007; Tavakoli
et al., 2009).
Aberrant imprinting of iPSCs, as referred to above (Stadtfeld et al.,
2010), appears not to be unique to iPSCs. It has also been reported in
other pluripotent cells types, notably EpiSCs derived from
NT-blastocysts (Maruotti et al., 2010). Although EpiSC could be iso-
lated with a similar efﬁciency from both fertilized and NT-blastocysts,
a striking difference was observed with respect to the gene expression
proﬁles, with one-third of these differences being located on chromo-
some 11. In most cases, the genes imprinted were methylated on both
alleles, and, as a consequence, their expression was down-regulated in
cells derived from NT-blastocysts compared with counterparts from
fertilized blastocysts.
Conclusion
Current methods of observation and analysis reveal that iPSCs, ESCs
and NT-ESCs are not absolutely equivalent with respect to epigenetic
signature, differential potential or gene expression (Table I) (Chin
et al., 2009; Kim et al., 2010; Maruotti et al., 2010; Stadtfeld et al.,
2010). More importantly, it appears that iPSCs and ESCs in isolation
are themselves are not equivalent, despite sharing all the prerequisites
of pluripotency and capacity to self-renew. The reported transcrip-
tional or epigenetic differences between iPSCs and ESCs therefore
imply redundancies in the pluripotency network that have no overall
signiﬁcant impact on stem-cell pluripotency per se. These subtle differ-
ences may well be compounded by culture conditions and laboratory
practices as exempliﬁed by the work of Newman and Cooper (2010).
Therefore, these differences could potentially be eradicated or mini-
mized (managed) by integrating standard operating procedures with
respect to the handling of ESC and iPSC lines with respect to
culture conditions such as medium and extracellular matrices
(Table II).
Figure 1 Laboratory-speciﬁc differences rendered as a fuzzy cluster network. Reprinted from Newman and Cooper (2010) with permission from
Elsevier. In short, whole transcriptome analysis of human induced pluripotent cells (iPSC), embryonic stem cells (ESC) and ﬁbroblast lines, illustrating
distinct laboratory-speciﬁc gene expression signatures of PSCs. This ﬁgure demonstrates that individual laboratory-speciﬁc lines (both iPSC and ESC)
cluster. In some cases, the transcriptional proﬁles of different laboratories are clustered (Daley, Sakurada and Lanza/Kim), which may reﬂect labora-
tory derivation and stem cell culturing practices.
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Table I Overview of similarities and differences observed in PSC populations.
ESCs hESCs iPSCs hiPSCs EpiSCs NT-EpiSCs Somatic
cell
Properties
Pluripotency
and self-renewal
Yes Yes Yes Yes Yes Yes No
LIF/BMP4
dependent
Yes No Yes No No No ND
FGF2/Activin
dependent
No Yes No Yes Yes Yes ND
Chimaera and
4N generation
Yes ND Contribute to chimaeras dependent
on epigenetic status
ND ND Corrected by deletion of
Xist, this gives increased
efﬁciency of cloned live
animals (Inoue et al.,
2010).
No
4N animals—only when DLk1-Dio3
locus active (Gtl2on)
4N—ND
Transcriptome Unique
signatures
observed
(Sharova et al.,
2007)
Unique signatures
observed (Abeyeta
et al., 2004;
Allegrucci and
Young, 2007)
Very similar to ESCs but differences
observed (Stadtfeld et al., 2010)
Unique miR signatures observed
by Malchenko et al. (2010), Chin
et al. (2009), Wilson et al. (2009)
Very similar to ESCs See below: transcriptional
differences as a
consequence of aberrant
epigenetic proﬁles
(Maruotti et al., 2010)
Unique
signatures—
tissue speciﬁc
Transcriptional similar to hESCs
(Chin et al., 2009, 2010; Guenther
et al., 2010). Newman and
Cooper (2010) demonstrate that
expression patterns laboratory
speciﬁc
Aberrant
epigenetic
proﬁles
ND ND Epigenetic memory of somatic origin
early passage (Kim et al., 2010; Polo
et al., 2010). Epigenetic memory
removed with extended passaging or
treatment with small molecules (as
suggested by Stadtfeld et al., 2010)
rendering functionally equivalent to
ESCs
Epigenetic memory of somatic
origin early passage (Marchetto
et al., 2009; Ghosh et al., 2010)
Aberrant Xist
expression can be
corrected, thus
generating live
animals (Inoue et al.,
2010)
Many differences
imprinting/epigenetic 30%
on chromosome 11.
(Maruotti et al., 2010)
No
ESCs, embryonic stem cells; hESCs, human embryonic stem cells; iPSCs, induced pluripotent stem cells; hiPSCs, human induced pluripotent stem cells; EpiSCs, epiblast-derived stem cells (post-implantation); NT-EpiSCs, epiblast-derived stem
cells (post-implantation) derived from somatic cell nuclear transfer; red indicates human source; blue indicates mouse source; purple indicates mouse epiblast source; ND, not described; LIF, leukaemia inhibitory factor; BMP4, bone
morphogenic factor; FGF2, ﬁbroblast growth factor 2.
Induced
pluripotent
stem
cells
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Incomplete reprogramming of iPSCs is probably a consequence of
the process being stochastic (Li et al., 2009; Utikal et al., 2009). The
reprogramming process requires only four factors and it takes
around a month to generate ES-like colonies. It is apparent from the
work of Stadtfeld et al. (2010) that only a small percentage of gener-
ated pluripotent iPSCs are similar to their ESC counterparts in that
they can contribute to a live animal in tetraploid complementation.
Getting back to the crux, are iPSC cells functionally equivalent to
ESCs? Kim et al. (2010), Chin et al. (2009) and Polo et al. (2010)
demonstrated that iPSCs, in early passage cultures, have a residual epi-
genetic memory of the tissue from which they were derived. In
addition, variation both at the epigenetic level and at the transcrip-
tional level occurs in other pluripotent cell populations, as discussed
above. Yet, importantly, all these cell types share the common fea-
tures of pluripotency and the ability to self-renew indeﬁnitely. iPSCs
generated using present-day methods appear to be very similar to
ESCs with the above subtle differences, so there is still room for
improvement. Stadtfeld et al. (2010) demonstrated that signatures of
previous identity can be erased with relative ease and an ESC identity
re-afﬁrmed by the use of small molecules such as VPA. In addition,
simply extended passaging causes amnesia within iPSCs! These obser-
vations may be indicative of a passive mechanism of epigenetic
re-assertion. Very recently, Inoue et al. (2010) have demonstrated
that deletion of Xist on the active X-chromosome restored normal
global gene expression and resulted in increased cloning efﬁciency.
Thus, it is apparent that we do not fully understand the mechanisms
responsible for cellular re-assignment and it will require further inves-
tigation and reﬁnement if we are to do so. To understand the impli-
cations of epigenetic memory, we need to consider the intended
use of the reprogrammed cell population in question and establish a
gold standard cell against which to assess it. Finally, other areas of
reprogramming are rapidly evolving, such as trans-differentiation of
one somatic cell type to another by forced expression of key
transcription factors (Ieda et al., 2010; Vierbuchen et al., 2010).
When it comes to assessing their practical beneﬁts, the same concerns
will apply.
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